These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 19340527

  • 1. Relationship between maximum standardized uptake value (SUVmax) of lung cancer and lymph node metastasis on FDG-PET.
    Nambu A, Kato S, Sato Y, Okuwaki H, Nishikawa K, Saito A, Matsumoto K, Ichikawa T, Araki T.
    Ann Nucl Med; 2009 May; 23(3):269-75. PubMed ID: 19340527
    [Abstract] [Full Text] [Related]

  • 2. Use of maximum standardized uptake value on fluorodeoxyglucose positron-emission tomography in predicting lymph node involvement in patients with primary non-small cell lung cancer.
    Muto J, Hida Y, Kaga K, Ohtaka K, Okamoto S, Tamaki N, Nakada-Kubota R, Hirano S, Matsui Y.
    Anticancer Res; 2014 Feb; 34(2):805-10. PubMed ID: 24511016
    [Abstract] [Full Text] [Related]

  • 3. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y, Suzuki K, Takamochi K, Matsunaga T, Oh S.
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [Abstract] [Full Text] [Related]

  • 4. Predictive value of primary fluorine-18 fluorodeoxyglucose standard uptake value for a better choice of systematic nodal dissection or sampling in clinical stage ia non--small-cell lung cancer.
    Li X, Zhang H, Xing L, Xu X, Xie P, Ma H, Zhang L, Chen M, Sun X, Xu W, Chen L, Yu J.
    Clin Lung Cancer; 2013 Sep; 14(5):568-73. PubMed ID: 23835164
    [Abstract] [Full Text] [Related]

  • 5. Differential diagnosis between (18)F-FDG-avid metastatic lymph nodes in non-small cell lung cancer and benign nodes on dual-time point PET/CT scan.
    Suga K, Kawakami Y, Hiyama A, Sugi K, Okabe K, Matsumoto T, Ueda K, Tanaka N, Matsunaga N.
    Ann Nucl Med; 2009 Aug; 23(6):523-31. PubMed ID: 19444550
    [Abstract] [Full Text] [Related]

  • 6. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
    Nakamura H, Saji H, Marushima H, Kimura H, Tagaya R, Kurimoto N, Hoshikawa M, Takagi M.
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the factors affecting the maximum standardized uptake value of metastatic lymph nodes in different histological types of non-small cell lung cancer on PET-CT.
    Wang Y, Ma S, Dong M, Yao Y, Liu K, Zhou J.
    BMC Pulm Med; 2015 Mar 08; 15():20. PubMed ID: 25880540
    [Abstract] [Full Text] [Related]

  • 8. Prediction of Pathologic Grade and Prognosis in Mucoepidermoid Carcinoma of the Lung Using ¹⁸F-FDG PET/CT.
    Park B, Kim HK, Choi YS, Kim J, Zo JI, Choi JY, Shim YM.
    Korean J Radiol; 2015 Mar 08; 16(4):929-35. PubMed ID: 26175595
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Mar 08; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 10. Dual-time-point F-18 FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer.
    Shinya T, Rai K, Okumura Y, Fujiwara K, Matsuo K, Yonei T, Sato T, Watanabe K, Kawai H, Sato S, Kanazawa S.
    Clin Nucl Med; 2009 Apr 08; 34(4):216-21. PubMed ID: 19300050
    [Abstract] [Full Text] [Related]

  • 11. [Significance of dual-time-point 18F-FDG PET imaging in evaluation of hilar and mediastinal lymph node metastasis in non-small-cell lung cancer].
    Hu M, Yu JM, Liu NB, Liu LP, Guo HB, Yang GR, Zhang PL, Xu XQ.
    Zhonghua Zhong Liu Za Zhi; 2008 Apr 08; 30(4):306-9. PubMed ID: 18788639
    [Abstract] [Full Text] [Related]

  • 12. Ratio of Lymph Node to Primary Tumor SUV on PET/CT Accurately Predicts Nodal Malignancy in Non-Small-Cell Lung Cancer.
    Mattes MD, Moshchinsky AB, Ahsanuddin S, Rizk NP, Foster A, Wu AJ, Ashamalla H, Weber WA, Rimner A.
    Clin Lung Cancer; 2015 Nov 08; 16(6):e253-8. PubMed ID: 26163919
    [Abstract] [Full Text] [Related]

  • 13. Clinicopathologic Significance of False-Positive Lymph Node Status on FDG-PET in Lung Cancer.
    Endoh H, Yamamoto R, Ichikawa A, Shiozawa S, Nishizawa N, Satoh Y, Oriuchi N.
    Clin Lung Cancer; 2021 May 08; 22(3):218-224. PubMed ID: 32654926
    [Abstract] [Full Text] [Related]

  • 14. Implication of ¹⁸F-Fluorodeoxyglucose Uptake of Affected Axillary Lymph Nodes in Cases with Breast Cancer.
    Fujii T, Yajima R, Tatsuki H, Oosone K, Kuwano H.
    Anticancer Res; 2016 Jan 08; 36(1):393-7. PubMed ID: 26722071
    [Abstract] [Full Text] [Related]

  • 15. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.
    Li M, Liu N, Hu M, Shi F, Yuan S, Zhang P, Fu Z, Yang G, Yu J.
    Lung Cancer; 2009 Mar 08; 63(3):383-6. PubMed ID: 18635284
    [Abstract] [Full Text] [Related]

  • 16. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
    Yilmaz M, Adli M, Celen Z, Zincirkeser S, Dirier A.
    Nucl Med Commun; 2010 Jun 08; 31(6):526-31. PubMed ID: 20215979
    [Abstract] [Full Text] [Related]

  • 17. Prediction of true-negative lymph node metastasis in clinical IA non-small cell lung cancer by measuring standardized uptake values on positron emission tomography.
    Takenaka T, Yano T, Morodomi Y, Ito K, Miura N, Kawano D, Shoji F, Baba S, Abe K, Honda H, Maehara Y.
    Surg Today; 2012 Oct 08; 42(10):934-9. PubMed ID: 22864936
    [Abstract] [Full Text] [Related]

  • 18. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE, Redwine J, Foster C, Abella E, Lown T, Lau D, Follette D.
    J Thorac Cardiovasc Surg; 2008 Mar 08; 135(3):615-9. PubMed ID: 18329480
    [Abstract] [Full Text] [Related]

  • 19. Semiquantitative assessment of fluorodeoxyglucose uptake in primary tumours on dynamic PET/computed tomography for lymph node metastasis evaluation in patients with lung cancer: a prospective study.
    Yamanaka M, Shinya T, Otomi Y, Kubo M, Arai Y, Toba H, Bando Y, Otsuka H, Harada M.
    Nucl Med Commun; 2020 Nov 08; 41(11):1189-1198. PubMed ID: 32796454
    [Abstract] [Full Text] [Related]

  • 20. Diagnostic performance of (18)F-FDG PET/CT for lymph node staging in patients with operable non-small-cell lung cancer and inflammatory lung disease.
    An YS, Sun JS, Park KJ, Hwang SC, Park KJ, Sheen SS, Lee S, Lee KB, Yoon JK.
    Lung; 2008 Nov 08; 186(5):327-36. PubMed ID: 18670805
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.